Anxiety & Panic6 min read

Buspirone vs. SSRIs for Anxiety: How They Compare

Khaled Hamed, PMHNP-C

Written Jun 21, 2026 · Updated Jun 21, 2026

Medically reviewed by: Khaled Hamed, PMHNP-C

Two people with anxiety can walk out of an appointment with two different prescriptions - one with an SSRI, one with buspirone - and both can be right. They work differently, suit different situations, and have different trade-offs. Here's how they actually compare.

The short version: SSRIs are the first-line medication for most anxiety disorders, with the broadest evidence. Buspirone is a non-addictive alternative approved specifically for generalized anxiety, useful when an SSRI isn't a good fit - but it isn't a match for every type of anxiety, and the proof that it works as well as an SSRI is limited.

What each one is

SSRIs (like sertraline, escitalopram, and others covered in our guide to antidepressants for anxiety) raise available serotonin and are used across the full range of anxiety disorders. Buspirone works differently - on a specific serotonin receptor - and is in its own class. It isn't sedating, it doesn't cause physical dependence, and it has no abuse potential, which is part of its appeal.

How they compare

How well they work. SSRIs and SNRIs have the strongest, broadest evidence and are first-line for anxiety (Slee et al., 2019). Buspirone clearly beats placebo for generalized anxiety - a Cochrane review of 36 trials and nearly 5,900 people found it effective, with a number-needed-to-treat of about 4.4 (Chessick et al., 2006). The honest catch: that same review could not conclude buspirone is as effective as antidepressants, so "works" and "works as well as an SSRI" aren't the same claim.

How fast. Neither is quick. Both take weeks to reach effect - buspirone typically around 4 to 6 weeks, similar to the timeline for an SSRI. If you're expecting same-day calm, neither fits; there's more on that in our piece on how long an SSRI takes to work.

Daily routine. SSRIs are usually once a day. Buspirone has a short half-life and is taken two to three times daily - easy to forget, which trips some people up.

Side effects. SSRIs commonly bring early activation, GI effects, and sexual side effects with longer use. Buspirone tends to be lighter - less sedation, no sexual dysfunction, no dependence - though it can cause dizziness or nausea. For someone bothered by an SSRI's sexual side effects, that difference matters.

What each is good for. SSRIs cover generalized anxiety, panic disorder, social anxiety, and more. Buspirone is really a generalized-anxiety medication - it isn't effective for panic disorder, and it tends to work less well in people who've recently taken benzodiazepines.

When a clinician might choose buspirone

Buspirone often comes up for generalized anxiety when someone wants to avoid an SSRI's sexual side effects, can't tolerate one, or specifically wants something non-sedating with no dependence risk. It's also used as an add-on to boost a partial SSRI response. For the right person with generalized anxiety, it's a genuinely reasonable choice.

When an SSRI is usually the better bet

If the picture includes panic disorder, social anxiety, OCD-type symptoms, or depression alongside the anxiety, an SSRI's broader reach usually wins. SSRIs also have the deeper evidence base across anxiety disorders, which is why they remain first-line.

The honest bottom line

This isn't a contest with one winner. SSRIs are first-line and the safer default for most anxiety, especially beyond generalized anxiety. Buspirone is a legitimate, lower-burden option for generalized anxiety - sometimes instead of an SSRI, often alongside one. The right answer depends on which type of anxiety you have, what side effects you're trying to avoid, and your history. If you're unsure where you land, a quick anxiety self-check can help you describe your symptoms before a visit.

If anxiety is wearing you down - or if you're in crisis or having thoughts of harming yourself - please reach out; you can call or text 988, the Suicide & Crisis Lifeline, any time.

Book your first evaluation to talk through which option fits your situation.

If any of this sounds familiar, you don't have to sort it out alone - book your first evaluation and we'll take it from there.

By the numbers

Each figure links to its primary source.

36 trials; ~5,900 people; NNT ~4.4
A Cochrane review of 36 trials and nearly 5,900 people found azapirones (including buspirone) effective for generalized anxiety versus placebo, with a number-needed-to-treat of about 4.4 - but could not establish superiority over antidepressants.Source: Chessick et al., Cochrane, 2006
89 trials; SSRIs/SNRIs first-line
A 2019 network meta-analysis of 89 trials found SSRIs and SNRIs effective for generalized anxiety disorder and supports them as first-line treatment.Source: Slee et al., Lancet, 2019

Frequently asked questions

Is buspirone as effective as an SSRI for anxiety?

It clearly works better than placebo for generalized anxiety, but the evidence doesn't establish it as equal to SSRIs, which remain first-line with broader proof. For the right person with generalized anxiety it's still a reasonable choice.

Which works faster, buspirone or an SSRI?

Neither is fast - both take weeks. Buspirone usually takes about 4 to 6 weeks, similar to an SSRI.

Does buspirone have fewer side effects than SSRIs?

Often, yes. It doesn't cause sexual dysfunction or dependence and isn't sedating, though it can cause dizziness or nausea and is taken two to three times a day.

Can buspirone treat panic attacks?

Not really. Buspirone is a generalized-anxiety medication; the evidence doesn't support it for panic disorder. SSRIs are the better fit there.

Can you take buspirone and an SSRI together?

Yes, that's a common approach - buspirone is sometimes added to boost a partial response to an SSRI. It's a decision to make with your prescriber.

Why might a clinician choose buspirone over an SSRI?

Usually for generalized anxiety when someone wants to avoid SSRI sexual side effects, can't tolerate an SSRI, or wants a non-sedating option with no dependence risk.

References

  1. American Psychiatric Association. (2022). Diagnostic and Statistical Manual of Mental Disorders (5th ed., text rev.; DSM-5-TR). American Psychiatric Publishing.
  2. Chessick CA, Allen MH, Thase ME, et al. Azapirones for generalized anxiety disorder. Cochrane Database of Systematic Reviews. 2006, Issue 3. Art. No.: CD006115.
  3. Slee A, Nazareth I, Bondaronek P, Liu Y, Cheng Z, Freemantle N. Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis. Lancet. 2019;393(10173):768-777.
  4. Imai H, Tajika A, Chen P, et al. Azapirones versus placebo for panic disorder in adults. Cochrane Database of Systematic Reviews. 2014, Issue 9. Art. No.: CD010828.
  5. Institute for Quality and Efficiency in Health Care (IQWiG). Generalized anxiety disorder: Treatment options. InformedHealth.org. NCBI Bookshelf.

Medical disclaimer: This article is for informational purposes only and does not constitute medical advice. It does not establish a provider–patient relationship. Always consult a qualified healthcare provider for diagnosis and treatment.

Ready to take the next step?

Talk to a licensed psychiatric provider about evidence-based treatment.

Book your first evaluation